BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• 

  Drug Development

  Aimmune Presents New Peanut Allergy Data and Presses for Real-World Data Approaches

  AR101 is an investigational, peanut-derived, biologic drug candidate for oral immunotherapy in patients with peanut allergy. It delivers a daily dose of peanut protein with a consistent protein profile.

  November 8, 2019

   · 

  3 min read

   · 

  Mark Terry
• 

  FDA

  FDA Approves Celgene and Acceleron’s Treatment for Rare Blood Disease

  The approval marks the first approved treatment in the United States for this condition.

  November 8, 2019

   · 

  3 min read

   · 

  Alex Keown
• 

  Roche Terminates Myostatin Inhibitor for DMD One Year After Pfizer Did the Same

  Roche intends to hold two global meetings with members of the DMD community to provide the stakeholders with as much information as possible.

  November 8, 2019

   · 

  2 min read

   · 

  Alex Keown
• 

  Policy

  What Are Some Legal Challenges that Come Along with Diversity and Inclusion in the Workplace?

  The legal challenges of diversity in the workplace is an issue that every human resources professional needs to take control of to ensure optimal inclusion.

  November 8, 2019

   · 

  5 min read

   · 

  Don Potochny
• 

  Drug Development

  Clinical Catch-Up: November 4-8

  It was a busy week for clinical trial updates for the first week of November. Here’s a look.

  November 8, 2019

   · 

  6 min read

   · 

  Mark Terry
• 

  Career Advice

  The Benefits of Different Life Sciences Career Paths

  Understanding which direction to take can be challenging for many professionals, whether they are in an early career stage, or later in their career.

  November 8, 2019

   · 

  3 min read

   · 

  Porschia Parker
• 

  Drug Development

  Daiichi Sankyo’s Hypertension Drug Hits Mark in Diabetic Nephropathy Trial

  The trial demonstrated that patients receiving esaxerenone has a significantly higher Urine Albumin-to-Creatinine Ratio (UACR) of 22.1% compared to 4.0% on placebo.

  November 8, 2019

   · 

  3 min read

   · 

  Mark Terry
• 

  Biopharma Increasingly Shifting Marketing Dollars to Digital Channels

  The report found that currently biopharma puts about 20% of its marketing budget into digital marketing, but expects to increase that by more than 70% over the next six years.

  November 8, 2019

   · 

  3 min read

   · 

  Mark Terry
• 

  Pharm Country

  Aurobindo is the Latest Company to Recall Ranitidine Medications

  This week, Aurobindo Pharma USA announced the recall of one lot of ranitidine tablets and 37 lots of ranitidine capsules and syrup.

  November 8, 2019

   · 

  2 min read

   · 

  Alex Keown
• 

  Lone Star Bio

  Animal Study Shows Rapamycin May Prevent Age-Related Brain Vascular Deterioration

  Could an immunosuppressant boost cognition in senior citizens? A recent animal study from the University of Texas Health Science Center at San Antonio suggests the possibility.

  November 8, 2019

   · 

  2 min read

   · 

  Alex Keown